{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:28:31Z","timestamp":1780514911013,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,8]]},"DOI":"10.7759\/cureus.106679","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:59:43Z","timestamp":1775692783000},"source":"Crossref","is-referenced-by-count":1,"title":["Vancomycin Re-Exposure-Induced Immune Hemolytic Anemia"],"prefix":"10.7759","author":[{"given":"Yiwen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:18-55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref2","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera FR","year":"2015","unstructured":"Bruniera FR, Ferreira FM, Saviolli LR, et al.. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015, 19:694-700.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref3","article-title":"Vancomycin infusion reaction","author":"Martel TJ","year":"2025","unstructured":"Martel TJ, Jamil RT, Afzal M. Vancomycin infusion reaction. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/00185787251341739","article-title":"Vancomycin-induced DRESS syndrome: a systematic review of case reports","author":"Bhumireddy SK","year":"2025","unstructured":"Bhumireddy SK, Gudla SS, Vadaga AK, Nandula MS. Vancomycin-induced DRESS syndrome: a systematic review of case reports. Hosp Pharm. 2025, 10.1177\/00185787251341739","journal-title":"Hosp Pharm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1539","article-title":"Vancomycin-induced immune hemolytic anemia - a case report and literature review","volume":"15","author":"Song Y","year":"2025","unstructured":"Song Y, Ali M, Shaikh R, Bersma A, Patel HY. Vancomycin-induced immune hemolytic anemia - a case report and literature review. J Community Hosp Intern Med Perspect. 2025, 15:85-9. 10.55729\/2000-9666.1539","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009801","article-title":"Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study","volume":"8","author":"Maquet J","year":"2024","unstructured":"Maquet J, Lafaurie M, Michel M, Lapeyre-Mestre M, Moulis G. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study. Blood Adv. 2024, 8:817-26. 10.1182\/bloodadvances.2023009801","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084296","article-title":"Autoimmune hemolytic anemias: classifications, pathophysiology, diagnoses and management","volume":"25","author":"Loriamini M","year":"2024","unstructured":"Loriamini M, Cserti-Gazdewich C, Branch DR. Autoimmune hemolytic anemias: classifications, pathophysiology, diagnoses and management. Int J Mol Sci. 2024, 25:10.3390\/ijms25084296","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5603\/jtmh.106171","article-title":"Drug-induced immune hemolytic anemia - the influence of selected drugs on immunohematology testing","volume":"18","author":"Mazur U","year":"2025","unstructured":"Mazur U, Kunysz M, Pacyna K. Drug-induced immune hemolytic anemia - the influence of selected drugs on immunohematology testing. J Transfus Med Hemost. 2025, 18:17-22. 10.5603\/jtmh.106171","journal-title":"J Transfus Med Hemost"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-467","article-title":"Drug-dependent antibodies with immune hemolytic anemia in AIDS patients","volume":"19","author":"Gonz\u00e1lez CA","year":"2003","unstructured":"Gonz\u00e1lez CA, Guzm\u00e1n L, Nocetti G. Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematology. 2003, 19:10-5.","journal-title":"Immunohematology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14362","article-title":"Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody","volume":"58","author":"Gniadek TJ","year":"2018","unstructured":"Gniadek TJ, Arndt PA, Leger RM, Zydowicz D, Cheng EY, Zantek ND. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody. Transfusion. 2018, 58:181-8. 10.1111\/trf.14362","journal-title":"Transfusion"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5848","article-title":"Vancomycin spacer-induced hemolysis","volume":"11","author":"Sudhakaran A","year":"2019","unstructured":"Sudhakaran A, Baburaj A, Banerjee K, Essrani R. Vancomycin spacer-induced hemolysis. Cureus. 2019, 11:10.7759\/cureus.5848","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39191","article-title":"Vancomycin-induced hemolytic anemia","volume":"15","author":"Siddiqui F","year":"2023","unstructured":"Siddiqui F, Cheema A, Kamran A. Vancomycin-induced hemolytic anemia. Cureus. 2023, 15:10.7759\/cureus.39191","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000045544","article-title":"Life-threatening vancomycin-induced immune hemolytic anemia: a rare case report","volume":"104","author":"Peng JC","year":"2025","unstructured":"Peng JC, Gao Y. Life-threatening vancomycin-induced immune hemolytic anemia: a rare case report. Medicine (Baltimore). 2025, 104:10.1097\/MD.0000000000045544","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1686669","article-title":"Case report: a severe drug-induced immune hemolytic anemia caused by vancomycin","volume":"12","author":"Xie Y","year":"2025","unstructured":"Xie Y, Wang Z, Deng D, et al.. Case report: a severe drug-induced immune hemolytic anemia caused by vancomycin. Front Med (Lausanne). 2025, 12:10.3389\/fmed.2025.1686669","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","author":"Garratty G","year":"2009","unstructured":"Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009, 73-9. 10.1182\/asheducation-2009.1.73","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V96.7.2329","article-title":"Modulation of hemostatic mechanisms in bacterial infectious diseases","volume":"96","author":"Tapper H","year":"2000","unstructured":"Tapper H, Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood. 2000, 96:2329-37.","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1497-9573","article-title":"Iron-driven alterations on red blood cell-derived microvesicles amplify coagulation during hemolysis via the intrinsic tenase complex","volume":"122","author":"Delvasto-N\u00fa\u00f1ez L","year":"2022","unstructured":"Delvasto-N\u00fa\u00f1ez L, Roem D, Bakhtiari K, van Mierlo G, Meijers JC, Jongerius I, Zeerleder SS. Iron-driven alterations on red blood cell-derived microvesicles amplify coagulation during hemolysis via the intrinsic tenase complex. Thromb Haemost. 2022, 122:80-91. 10.1055\/a-1497-9573","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050445","article-title":"Laboratory monitoring of direct oral anticoagulants (DOACs)","volume":"9","author":"Dunois C","year":"2021","unstructured":"Dunois C. Laboratory monitoring of direct oral anticoagulants (DOACs). Biomedicines. 2021, 9:10.3390\/biomedicines9050445","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479092-vancomycin-re-exposure-induced-immune-hemolytic-anemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:59:44Z","timestamp":1775692784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479092-vancomycin-re-exposure-induced-immune-hemolytic-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.106679","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,8]]}}}